FUNDACIÓN CT NAC DE INVESTIGACIONES ONCOLÓGICAS CARLOS III has a total of 11 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Chile. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ZELTIA S A, TACTICAL THERAPEUTICS INC and BENCHERIF MEROUANE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Chile | 1 | |
#4 | New Zealand | 1 | |
#5 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Microorganisms | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Pastor Fernández Joaquín | 5 |
#2 | Varela Busto Carmen | 4 |
#3 | Martínez González Sonia | 4 |
#4 | Blanco Aparicio Carmen | 4 |
#5 | Murga Costa Matilde | 3 |
#6 | Lopez Contreras Andrés Joaquín | 3 |
#7 | Renner Oliver | 3 |
#8 | Toledo Lázaro Luis Ignacio | 3 |
#9 | Rodríguez Arísteguí Sonsoles | 3 |
#10 | Rico Ferreira María Del Rosario | 2 |
Publication | Filing date | Title |
---|---|---|
EP2979706A1 | Methods for treating liver or pancreatic cancer | |
EP2814979A1 | Mammalian homologues of flower, their use in cancer diagnostics, prevention and treatment | |
NZ618157A | Macrocyclic compounds as protein kinase inhibitors | |
EP2480549A1 | Fused imidazo[3,2-d]pyrazines as PI3 kinase inhibitors | |
EP2402038A1 | Telomerase reverse transcriptase for protection against ageing | |
EP2193133A2 | Imidazolothiadiazoles for use as protein kinase inhibitors |